Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis
2018; Springer Science+Business Media; Volume: 145; Issue: 2 Linguagem: Inglês
10.1007/s00432-018-2805-3
ISSN1432-1335
AutoresBiagio Ricciuti, Carlo Genova, Andrea De Giglio, Maria Bassanelli, Maria Giovanna Dal Bello, Giulio Metro, Marta Brambilla, Sara Baglivo, Francesco Grossi, Rita Chiari,
Tópico(s)CAR-T cell therapy research
Referência(s)